 Connection
Jason Hoppe to Narcotic Antagonists
This is a "connection" page, showing publications Jason Hoppe has written about Narcotic Antagonists.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
3.292 |
|
|
|
-
Lebin JA, Hensen C, Lun Z, Kwan BM, Goldberg EM, Burnham EL, Hoppe JA. Predictors of naltrexone prescribing for alcohol use disorder from the emergency department. Alcohol Clin Exp Res (Hoboken). 2025 Oct; 49(10):2310-2318.
Score: 0.777
-
Lebin JA, Mitchell K, Trinkley KE, Calcaterra SL, Lun Z, Hensen C, Hoppe JA. Clinical Decision Support to Increase Naloxone Co-prescribing from the Inpatient Setting. J Gen Intern Med. 2026 01; 41(1):18-25.
Score: 0.768
-
Sommers SW, Tolle HJ, Trinkley KE, Johnston CG, Dietsche CL, Eldred SV, Wick AT, Hoppe JA. Clinical Decision Support to Increase Emergency Department Naloxone Coprescribing: Implementation Report. JMIR Med Inform. 2024 11 06; 12:e58276.
Score: 0.730
-
Iscoe MS, Diniz Hooper C, Levy DR, Buchanan L, Dziura J, Meeker D, Taylor RA, D'Onofrio G, Oladele C, Sarpong DF, Paek H, Wilson FP, Heagerty PJ, Delgado MK, Hoppe J, Melnick ER. Adaptive decision support for addiction treatment to implement initiation of buprenorphine for opioid use disorder in the emergency department: protocol for the ADAPT Multiphase Optimization Strategy trial. BMJ Open. 2025 Feb 20; 15(2):e098072.
Score: 0.186
-
Comstock G, Truszczynski N, Michael SS, Hoppe J. Variability in Practice of Buprenorphine Treatment by Emergency Department Operational Characteristics. West J Emerg Med. 2024 Jul; 25(4):483-489.
Score: 0.178
-
Kelly TD, Hawk KF, Samuels EA, Strayer RJ, Hoppe JA. Improving Uptake of Emergency Department-initiated Buprenorphine: Barriers and Solutions. West J Emerg Med. 2022 Jul 11; 23(4):461-467.
Score: 0.155
-
Hawk K, Hoppe J, Ketcham E, LaPietra A, Moulin A, Nelson L, Schwarz E, Shahid S, Stader D, Wilson MP, D'Onofrio G. Consensus Recommendations on the Treatment of Opioid Use Disorder in the Emergency Department. Ann Emerg Med. 2021 09; 78(3):434-442.
Score: 0.144
-
Zuckerman M, Kelly T, Heard K, Zosel A, Marlin M, Hoppe J. Physician attitudes on buprenorphine induction in the emergency department: results from a multistate survey. Clin Toxicol (Phila). 2021 Apr; 59(4):279-285.
Score: 0.137
-
Frank JW, Levy C, Calcaterra SL, Hoppe JA, Binswanger IA. Naloxone Administration in US Emergency Departments, 2000-2011. J Med Toxicol. 2016 06; 12(2):148-56.
Score: 0.102
-
Heil JM, Lassiter JM, Salzman MS, Herring A, Hoppe J, Lynch M, Weiner SG, Roberts B, Haroz R. A qualitative assessment of emergency physicians' experiences with robust emergency department buprenorphine bridge programs. Acad Emerg Med. 2024 06; 31(6):576-583.
Score: 0.043
-
Melnick ER, Nath B, Dziura JD, Casey MF, Jeffery MM, Paek H, Soares WE, Hoppe JA, Rajeevan H, Li F, Skains RM, Walter LA, Patel MD, Chari SV, Platts-Mills TF, Hess EP, D'Onofrio G. User centered clinical decision support to implement initiation of buprenorphine for opioid use disorder in the emergency department: EMBED pragmatic cluster randomized controlled trial. BMJ. 2022 06 27; 377:e069271.
Score: 0.039
-
Kelly T, Hoppe JA, Zuckerman M, Khoshnoud A, Sholl B, Heard K. A novel social work approach to emergency department buprenorphine induction and warm hand-off to community providers. Am J Emerg Med. 2020 06; 38(6):1286-1290.
Score: 0.033
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|